Key facts
- This page summarizes Hadar Levy's Form 3 filing for Brainsway Ltd. (BWAY).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 16:03.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Footnote F2
This figure includes: (i) 16,800 ordinary shares and (ii) unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 31,250 ordinary shares vesting in equal quarterly installments until March 5, 2028 and (b) RSUs to receive 75,000 ordinary shares vesting in equal yearly installments until March 9, 2029, subject to certain vesting conditions.
Footnote F3
Stock options were granted on February 9, 2023, with the remaining options to purchase 80,000 ordinary shares vesting in equal quarterly installments until February 13, 2027, with acceleration in the event of a change of control.
Footnote F4
The exercise price is NIS 3.65 per share.
Footnote F5
Stock options were granted on March 5, 2024, with the remaining options to purchase 62,500 ordinary shares vesting in equal quarterly installments until March 5, 2028.
Footnote F6
The exercise price is NIS 11.17 per share.